Back to top

stock-price-change: Archive

Zacks Equity Research

Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for

Cytek Biosciences (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CTKBNegative Net Change RARENegative Net Change

Zacks Equity Research

Earnings Preview: Cirrus Logic (CRUS) Q2 Earnings Expected to Decline

Cirrus Logic (CRUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRUSNegative Net Change LSCCNegative Net Change

Zacks Equity Research

Analysts Estimate Circle Internet Group, Inc. (CRCL) to Report a Decline in Earnings: What to Look Out for

Circle Internet Group, Inc. (CRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRCLNegative Net Change

Zacks Equity Research

Corpay (CPAY) Reports Next Week: Wall Street Expects Earnings Growth

Corpay (CPAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPAYNegative Net Change

Zacks Equity Research

Fair Isaac (FICO) Reports Next Week: Wall Street Expects Earnings Growth

Fair Isaac (FICO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FICOPositive Net Change DTNegative Net Change

Zacks Equity Research

Foghorn Therapeutics Inc. (FHTX) Expected to Beat Earnings Estimates: Should You Buy?

Foghorn Therapeutics (FHTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FHTXNegative Net Change AMGNNegative Net Change

Zacks Equity Research

EyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?

EyePoint (EYPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EYPTNegative Net Change LQDANegative Net Change

Zacks Equity Research

Expedia (EXPE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Expedia (EXPE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EXPENegative Net Change

Zacks Equity Research

Esab (ESAB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Esab (ESAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ESABNegative Net Change

Zacks Equity Research

Datadog (DDOG) Earnings Expected to Grow: Should You Buy?

Datadog (DDOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DDOGNegative Net Change SRADNegative Net Change